Microbot Medical Inc.
MBOT
$1.46
-$0.04-2.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 128.54% | 93.92% | 226.87% | 116.94% | 47.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.68% | 46.47% | 20.64% | 17.00% | 48.27% |
| Operating Income | -66.21% | -43.00% | -20.64% | -17.00% | -48.27% |
| Income Before Tax | -60.77% | -41.14% | -2.12% | -11.26% | -41.99% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.77% | -41.14% | -2.12% | -11.26% | -41.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.77% | -41.14% | -2.12% | -11.26% | -41.99% |
| EBIT | -66.21% | -43.00% | -20.64% | -17.00% | -48.27% |
| EBITDA | -66.34% | -43.31% | -21.27% | -17.52% | -48.62% |
| EPS Basic | 12.62% | 34.65% | 73.90% | 61.89% | 42.23% |
| Normalized Basic EPS | 12.67% | 41.64% | 73.88% | 61.89% | 42.20% |
| EPS Diluted | 12.62% | 34.65% | 73.90% | 61.89% | 42.23% |
| Normalized Diluted EPS | 12.67% | 41.64% | 73.88% | 61.89% | 42.20% |
| Average Basic Shares Outstanding | 84.07% | 116.04% | 291.55% | 191.99% | 145.77% |
| Average Diluted Shares Outstanding | 84.07% | 116.04% | 291.55% | 191.99% | 145.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |